Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ALS-2200, VX-135
print preview
bookmark
share with colleague
General Information
Company
Alios BioPharma Inc.
Description
Nucleotide HCV NS5B polymerase inhibitor
Molecular Target
HCV NS5B polymerase
Mechanism of Action
HCV non-structural protein 5B inhibitor
Latest Stage of Development
Phase II
Indication
Hepatitis C virus (HCV)
Partner
Vertex Pharmaceuticals Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy